Dissecting the Biology Behind ADCs Webinar | Nov. 12th. Presented by Jane Lamerdin, Ph.D.

Thursday, November 12, 2026 · 8am PT | 11am ET | 4pm GMP. Dissecting the Biology Behind ADCs Webinar – Explore how integrated cell-based assays reveal the mechanisms that drive antibody-drug conjugate (ADC) activity and inform candidate selection. Presented by Jane Lamerdin, Ph.D., VP of R&D, Eurofins DiscoverX. ADCs combine the targeting specificity of monoclonal antibodies with potent cytotoxic payloads, but their activity depends on multiple interconnected cellular processes. Internalization, intracellular trafficking, payload release, and Fc-mediated activity can each influence therapeutic response, making it challenging to determine which mechanisms drive a candidate’s efficacy. In this webinar, Jane Lamerdin will discuss how integrated cell-based assays can characterize ADC mechanisms of action and generate functional insights to support candidate prioritization and preclinical development.